NASDAQ:MTEM
Molecular Templates Inc Stock News
$1.45
-0.0500 (-3.33%)
At Close: May 17, 2024
Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update
05:11pm, Wednesday, 15'th May 2024
AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery
AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discove
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
08:21am, Friday, 29'th Mar 2024
AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discove
AUSTIN, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discove
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March - Inspire Veterinary (NASDAQ:IVP), Fractyl Health (NASDAQ:GUTS)
08:08am, Tuesday, 19'th Mar 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Molecular Templates, Inc. Provides Interim Update
08:11am, Monday, 04'th Mar 2024
Monotherapy activity with PD-L1-targeting MT-6402 in Head and Neck Cancer; Unique pharmacodynamic effects with CTLA-4 targeting MT-8421 in on-going phase I study Monotherapy activity with PD-L1-target
Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
05:55pm, Thursday, 08'th Feb 2024
AUSTIN, Texas, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company developing novel thera
Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update
04:11pm, Monday, 13'th Nov 2023
AUSTIN, Texas, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discover
AUSTIN, Texas, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company developing novel therape
Molecular Templates to Participate in Upcoming Investor Conferences
04:12pm, Wednesday, 01'st Nov 2023
AUSTIN, Texas, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discover
Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer
04:11pm, Thursday, 28'th Sep 2023
AUSTIN, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company developing novel therap
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Molecular Templates Inc. (MTEM)
10:31am, Friday, 25'th Aug 2023
Molecular Templates Inc. (MTEM) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the sever
Molecular Templates Announces 1-for-15 Reverse Stock Split
11:22am, Friday, 11'th Aug 2023
AUSTIN, Texas, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM) (the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology wi
Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business Update
08:08am, Thursday, 10'th Aug 2023
AUSTIN, Texas, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discover
Molecular Templates Announces Executive Leadership Changes
04:11pm, Wednesday, 02'nd Aug 2023
AUSTIN, Texas, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company developing novel therap